Human leukemic cells: Biological action of exogenous human leukemic DNA

Intact exogenous human leukemie DNA derived from cells in culture was taken up by both normal and leukemic recipient human cells, wherein it migrates to the nucleus and becomes associated with host genome. Uptake of exogenous DNA averages about 15–20 percent and was relatively higher in leukemic than in normal cells in a given culture medium.Isologous and homologous human leukemic cells were more sensitive to inhibition by this exogenous DNA than were normal human cells. Both DNA and RNA synthesis were inhibited, but protein synthesis was stimulated — effects similar to those described consequent to exposure to certain viruses.Immunological studies of hamster cells treated with human leukemic DNA failed to show any presence of human surface antigens. The in vivo studies showed that this metabolically active radioactive DNA had migrated to several organs of hamsters and gerbils, the highest labeled DNA activity being found in the testis and kidney of these animals.Prolonged exposure to exogenous leukemic DNA resulted in marked phenotypic changes in normal human fibroblasts, which thus far appear to be heritable. Search for evidence of genotypic changes in these altered cells which might relate these observations to «neoplastic transformation is in progress.     

Cytology of leukemic lymphadenopathy

OBJECTIVE: To describe the cytomorphologic features of leukemic cells in lymph node aspiration material. STUDY DESIGN: We studied lymph node fine needle aspiration (FNA) smears of 36 leukemic patients. In 23 cases the lymphadenopathy was noticed simultaneously with marrow leukemia, and in the other 13 cases the lymphadenopathy was noticed during a relapse. Special stains, such as periodic acid Schiff, Sudan Black-B, Oil Red-O and nonspecific esterase, were used in special cases. RESULTS: Thirty-three cases were diagnosed as lymphoma, 1 as extramedullary hematopoiesis and 2 as leukemic involvement. CONCLUSION: Leukemic lymphadenopathy can be misdiagnosed as lymphoma on FNA smears. The clinical findings, previous history, hematologic studies and immunocytochemical studies are essential to the differentiation of leukemic smears from lymphoma. However, in some cases the leukemic infiltration can be diagnosed with certainty, provided that the smears show the characteristic findings, such as Auer rods and neoplastic promyelocytes with azurophilic granules.     

Magnesium contents of leukemic lymphocytes

In this study, magnesium concentrations were measured in lymphocytes from patients with acute myeloblastic leukemia (AML), chronic megalositer leukemia (KML) and acute lymphoblastic leukemia (ALL) before and after chemotherapy management, and results were compared with those of control subjects. Magnesium concentrations were higher in the patient groups compared with control values. However, no meaningful differences were found among magnesium concentrations of the patient groups themselves. Similarly, no statistically meaningful differences were found between lymphocyte magnesium concentrations before and after chemotherapy management in the patient groups. In the inter-correlation analysis, we observed no correlations between pre- and post-magnesium concentrations in patients' lymphocytes. It has been suggested that magnesium concentrations of leukemic lymphocytes might increase due to the high ATP requirement of the leukemic cells since magnesium is known to play an important part as a cofactor in most of the energy-producing reactions.     

Glycosphingolipids of normal and leukemic human leukocytes

Summary We have reviewed the studies on neutral glycosphingolipids and gangliosides of normal and leukemia human leukocytes. In this review, we examine (a) the glycosphingolipid composition of various leukocyte populations, (b) the differences in glycosphingolipids found among subsets of these cells, (c) the possible use of these compounds as markers of differentiation, and (d) the changes in glycosphingolipid composition that occur with leukemogenesis.